News Expect To See A Major Shake-Up in 2021 As...

Expect To See A Major Shake-Up in 2021 As CBD Market Reaches Brand Saturation Point

-

Advertising

THE CBD industry is changing and developing into niche sectors as it gains a better understanding of its customers’ needs.

Edibles look set to replace oils as the predominant delivery method with the UK set to become the European powerhouse in the months and years to come.

Tim Phillips, Managing Director of CBD-Intel.

And, with over 5,000 brands the market is close to saturation point – so expect to see a major shake-up in 2021.

This is the analysis of one of the European industry’s leading lights; Tim Phillips, Managing Director of CBD-Intel.

‘Is It Saturated, Yet?’

Speaking at the Global Cannabis Intelligence (GCI) Virtual Summit yesterday Mr Phillips showed some CBD-Intel research which highlighted how there are at least 5,000 active brands in the USA and Europe.

He said: “One of the main attributes of the CBD market has been the number of brands there are, in the market.

“That dynamic is continuing, and creating a really-fragmented market. We are still seeing a lot of brands enter the market. Which does beg the question ‘is it saturated yet?’ While it may not be, just yet, I suspect it’s about to be. 

“With the regulatory changes coming up we are going to see a big decline in the number of brands.”

Mr Phillips was referring to the moves towards Novel Food compliance in the UK, concerns over the safety of CBD in the USA and the European Union’s deliberations on CBD as a narcotic.

He continued: “We are going to see a lot of filtering out, particularly from those who do not want to go through the regulatory process, and are, frankly, not making the profits they thought they would be. 

“I think we are going to see some major declines from next year – and it will happen quickly.

“The margins on CBD product have been high for time time. This is what happens in fast-growth markets, but, eventually the market slows and that is what is happening, now.”

Edibles And Isolates

This has led to a fall in wholesale prices in Europe and the US and this is reflected in lower prices for consumers, too. 

He went on to say that the 10ml CBD sublingual oil is becoming the pre-eminent product and we will see more diversification with edibles becoming the most popular over the next few years 

The Novel Food rules are likely to lead to the dominance of CBD isolate, replacing full spectrum.

And, with the UK now leading the way on the route to compliance he sees this market rising by one-quarter to to £500m, annually, over the next few years.

One of the major trends is the development of niche products and the CBD sector is meeting this challenge by better understanding the needs of its consumers, or, groups of consumers.

A Focus On Customers Needs

“Those using topicals for sports injuries are a very different consumer to someone using it for sleep, and the sector is getting better at understanding this.”

In a separate discussion entitled ‘Building Relationships with Retailers & Cultivating Your Brand’s USP’ GCI Managing Director Jonathan Wiser quizzed some key industry figures.

These were; Jason White, of Curaleaf, Melissa Jochim, of High Beauty, Rebekah Hall, of South West Brands, Michael Bumgarner, of Cannuka and George Kruis, of fourfivecbd.

Ms Hall likewise elaborated on the changes taking place in the industry highlighting the progress of its Botanic Lab drinks brand.

“It’s encouraging to be talking about the true, real brand stories, and brand stories in CBD are no different to any other story; They have to be genuine and rooted in an original story and they have to engage the consumer. 

“We are at an exciting stage in this industry where those stories are no longer just about CBD; having CBD in a product is not the interesting thing, now.

“We have to create brands around ingredients which engage the consumer. At Botanic Lab our USP is using interesting ingredients, product innovation and delivering a unique customer experience. CBD happens to be one of those.” 

The GCI Virtual Summit continues today – Thursday November 12. For further info click here

Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Markets: US Firm Swoops For UK Medical Cannabis Company, EMMAC, Alphagreen, Ananda et al…

AMERICAN firm Halo Labs has snapped up UK medicinal cannabis supplier Canmart in a share-based deal. Kent-based Canmart was one...

Walking In The Light With Carlos Santana And Prohibition Partners

MUSIC legend Carlos Santana rounded-off this year’s second Prohibition Partners Live discussing his new cannabis venture, his relationship with...

European Commission Under Increasing Pressure To Scrap Its Classification Of CBD As A Narcotic Drug Following Court Ruling

THE European Court of Justice has handed the continent’s hemp and CBD industry a major boost - now the...

Huge Result For CBD Industry With Europe’s Top Court Saying It Is Not A Narcotic

THE KanaVape ruling is in and it's a massive win for the CBD industry with the ECJ saying that...

Advertising

KanaVape’s Antonin Cohen Speaks To BusinessCann After Winning His Six-Year CBD Court Battle With Europe

A JOYFUL Antonin Cohen has spoken of his delight - and relief - after successfully winning a court battle...

KanaVape Judgement Expected Soon; Stay Tuned To BusinessCann For Running Updates From 8.30am-ish GMT

TODAY could be a significant one in the history of Europe’s CBD industry with the European Court of Justice...

Must read

Markets: US Firm Swoops For UK Medical Cannabis Company, EMMAC, Alphagreen, Ananda et al…

AMERICAN firm Halo Labs has snapped up UK medicinal...

Walking In The Light With Carlos Santana And Prohibition Partners

MUSIC legend Carlos Santana rounded-off this year’s second Prohibition...

Advertising

You might also likeRELATED
Recommended to you